Bryan Stuart is the former President and CEO of Fulcrum Therapeutics, where he held the position from March 2021 to January 2023. He has a solid academic background, holding an MBA from the Kellogg School of Management at Northwestern University...
Bryan Stuart is the former President and CEO of Fulcrum Therapeutics, where he held the position from March 2021 to January 2023. He has a solid academic background, holding an MBA from the Kellogg School of Management at Northwestern University and a B.S. from the University of Illinois. Before stepping up to lead Fulcrum, Bryan served as Chief Operating Officer and held CEO roles at two other biotech firms focused on rare diseases. His tenure at Fulcrum saw the company focus on developing therapies for serious medical conditions. Interestingly, in 2022, he received a total compensation of about $792,450, but he did not receive additional bonuses for 2023 due to transitioning out of his role. His time as CEO coincided with significant fluctuations in stock trading, where he notably made trades valued at millions of dollars, showcasing his financial involvement with the company. Despite his departure, his legacy includes a focus on aligning leadership with the company's performance and a commitment to driving innovative solutions in the biotech space.